Skip to main content
. Author manuscript; available in PMC: 2023 Jan 4.
Published in final edited form as: J Immunol. 2007 Feb 1;178(3):1791–1799. doi: 10.4049/jimmunol.178.3.1791

FIGURE 4.

FIGURE 4.

The Treg cells induced by Salmonella-CFA/I vaccination suppress effector T cells, and their in vivo inactivation results in enhanced clinical disease. A, CD25CD4+ and CD25+CD4+ T cells from spleens, MLN, and HNLN were cell sorted from mice orally immunized with H696 for 2 wk. Teff (1 × 105) cells with feeder (1 × 105) cells were cultured with CFA/I fimbriae and with or without Treg (5 × 104) cells for 4 days. During the last 18 h of culture, cells were pulsed with [3H]TdR. Proliferation in the absence of Treg cells was set at zero inhibition. Depicted is the percent inhibition upon coculture with splenic, MLN, or HNLN Treg cells. One of three experiments is depicted. B, One week before PLP139–151 challenge, mice (five per group) orally immunized with H696 were treated in vivo with anti-CD25 mAb, rat IgG, or PBS on days −5 and −2 before challenge. Inactivation of Treg cells provoked greater EAE than the PBS-treated group. Normal rat IgG-treated mice vaccinated with H696 showed minimal EAE. *, p < 0.001 for anti-CD25-treated group vs H696-vaccinated or H696-vaccinated plus normal rat IgG-treated mice.